On March 24th, new briefs were filed in the TikTok MDL as mandated by U.S. District Judge John Z. Lee. These fillings came in response to the judge’s questions in reference to the proposed settlement of March 2nd. The judge had requested further information about...
Litigation Update: Zofran MDL Set to Start in the Fall
U.S. District Judge F. Dennis Saylor IV, who is handling the first bellwether in the MDL that relates to Zofran, has announced the date of October 18th as the potential start of the trial. Plaintiffs allege that Zofran, a drug manufactured by GlaxoSmithKline to ease...
Litigation Update: Elmiron MDL Sent to New Jersey
On Tuesday, December 15th the JPML sent all Elmiron cases to be tried in New Jersey by U.S. Judge Brian R. Martinotti. The judge had been handling Elmiron lawsuits and had already set up processes resembling those typically followed in MDLs. Because those efforts were...
Litigation Update: JPML to Decide on Elmiron’s Litigation Venue
At the last JPML hearing held on Thursday, December 4th, the panel heard from counsel for Johnson & Johnson and lawyers for plaintiffs. Both sides presented arguments for creating an MDL for all Elmiron cases in New Jersey federal court. Those proposing NJ as...
Litigation Update: FDA Denies Request to Add Birth Defect Warning to Zofran’s Label
The FDA has notified Novartis that it has rejected their request to add a birth defect warning to Zofran’s label. Plaintiffs claim that Zofran, a drug used to treat nausea for cancer and surgery patients, was also promoted by GlaxoSmithKline - the original developer...
Litigation Update: Johnson & Johnson’s Loses Appeal on $2.1B St. Louis Talc Verdict
On November 3, Missouri’s Supreme Court refused to review a jury verdict for $2.1B that was delivered to 22 women who claimed that J&J’s talc-containing baby powder caused their ovarian cancer. That verdict was the result of a June 2018 trial where the jury found...
Litigation Update: Juul and Altria Avoid Racketeering Claims in Vaping Litigation
In an order issued on Friday, October 23, Judge Orrick denied plaintiffs’ claims on racketeering charges against Juul and Altria for their lack of specific proof to sustain those charges. Plaintiffs, however, have the option of modifying their filings to make them a...
Litigation Update: Purdue Pharma Pleads Guilty and Settles for $8.3 Billion
The DOJ has announced that Purdue Pharma, the maker of OxyContin, the opioid painkiller which had a big role in the U.S. opioid epidemic, has agreed to plead guilty to three federal criminal charges in addition to paying $8.3 billion. The agreement does not exonerate...
Litigation Update: Johnson & Johnson to Reach Deal to Settle 3,000 Opioid Cases
On Tuesday, October 13, J&J announced that it was increasing its settlement deal by $1 billion for a total of $5 billion in its efforts to put an end to almost 3,000 opioid lawsuits. This is part of the original $48 billion settlement framework proposed in 2019...
Litigation Update: Johnson & Johnson Fights Back Oklahoma’s Opioid Verdict
The Oklahoma court has ruled that it will allow organizations to file friend of the court briefs in support of J&J’s efforts to overturn a $465 million judgement for their role in contributing to the opioid epidemic in Oklahoma. The key issue in last week’s brief...